LIOPYLIOPYOTC
Loading
Operating Expenses Over TimeStable
Percentile Rank57
3Y CAGR+5.5%
5Y CAGR+4.7%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+5.5%/yr
vs +1.5%/yr prior
5Y CAGR
+4.7%/yr
Consistent
Acceleration
+4.0pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
3 yr
Consecutive growthStable
PeriodValueYoY Change
2025$171.07B+6.7%
2024$160.40B+0.2%
2023$160.09B+9.8%
2022$145.76B-1.5%
2021$147.93B+8.9%
2020$135.80B-4.4%
2019$142.10B+3.3%
2018$137.53B-35.1%
2017$212.06B+1.4%
2016$209.10B-